Trial Profile
A trial to study effectiveness and tolerability of low-dose oral oxycodone/naloxone added to anticonvulsant therapy for noncancer neuropathic pain
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Dec 2015
Price :
$35
*
At a glance
- Drugs Oxycodone/naloxone (Primary)
- Indications Pain
- Focus Therapeutic Use
- 06 Dec 2015 New trial record